Merck + Co., Inc.

Paul I Chang

Robert Segal

Peter K Siegl

Bertram Pitt

Allan I Goldberg

Duane B Snavely

Michael R Goldberg

Polly A Beere

Eva J Rucinska

Divakar Sharma

Angiotensin II receptor antagonists are useful in reducing and preventing mortality and sudden cardiac death in symptomatic heart failure patients. Losartan potassium has been shown to reduce mortality and sudden cardiac death in this patient population. Additionally, losartan potassium has been shown to reduce the need for hospitalization of symptomatic heart failure patients.

Method for reducing mortality with an angiotensin II antagonist

A method for the treatment of Meniere's disease comprising the administration of a medicament which modulates the IKs channel of the ear and thereby reducing endolymph production.

Method for treating Meniere's disease

Growing community of inventors

Doylestown, PA, United States of America

Paul I Chang